Literature DB >> 30446495

The genomic landscape of plasma cells in systemic light chain amyloidosis.

Eileen M Boyle1,2,3, Cody Ashby1, Christopher P Wardell1, Dorota Rowczenio4, Sajitha Sachchithanantham4, Yan Wang1, Sarah K Johnson1, Michael A Bauer1, Niels Weinhold1, Martin F Kaiser5, David C Johnson5, John R Jones5, Charlotte Pawlyn5, Paula Proszek5, Carolina Schinke1, Thierry Facon2, Charles Dumontet3, Faith E Davies1, Gareth J Morgan1, Brian A Walker1, Ashutosh D Wechalekar4.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30446495     DOI： 10.1182/blood-2018-08-872226

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Coagulation and fibrinolytic features in AL amyloidosis with abnormal bleeding and usefulness of tranexamic acid.

Authors:  Masahisa Arahata; Hiroyuki Takamatsu; Eriko Morishita; Yasuko Kadohira; Shinya Yamada; Akitada Ichinose; Hidesaku Asakura
Journal:  Int J Hematol       Date:  2020-01-03       Impact factor: 2.490

2.  Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis.

Authors:  Zuzana Chyra; Tereza Sevcikova; Petr Vojta; Janka Puterova; Lucie Brozova; Katerina Growkova; Jana Filipova; Martina Zatopkova; Sebastian Grosicki; Agnieszka Barchnicka; Wieslaw Wiktor Jedrzejczak; Anna Waszczuk-Gajda; Alexandra Jungova; Aneta Mikulasova; Marian Hajduch; Martin Mokrejs; Ludek Pour; Martin Stork; Lubica Harvanova; Martin Mistrik; Gabor Mikala; Pawel Robak; Anna Czyz; Jakub Debski; Lidia Usnarska-Zubkiewicz; Artur Jurczyszyn; Lukas Stejskal; Gareth Morgan; Fedor Kryukov; Eva Budinska; Michal Simicek; Tomas Jelinek; Matous Hrdinka; Roman Hajek
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

Review 3.  Genetic pathogenesis of immunoglobulin light chain amyloidosis: basic characteristics and clinical applications.

Authors:  Linchun Xu; Yongzhong Su
Journal:  Exp Hematol Oncol       Date:  2021-07-20

Review 4.  Daratumumab in the Treatment of Light-Chain (AL) Amyloidosis.

Authors:  Giovanni Palladini; Paolo Milani; Fabio Malavasi; Giampaolo Merlini
Journal:  Cells       Date:  2021-03-04       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.